Scientists design non-hallucinogenic psychedelic treatments potentially accelerating research on mental health benefits

  • Post author:
  • Post category:uncategorized

Researchers identified 5-hydroxytryptamine 2A (5-HT2A) receptor (5-HT2AR) signaling pathways associated with psychedelic potential.